CytlinkRetatrutide
Ordered Retatrutide from Cytlink? Mail in a sample (US only) and let us test it.
Test my supplyCytlink Retatrutide is dragged down by repeated identity failures, not marginal purity or fill misses. The October and November PharmLabs COAs for July 2026 and N/A Pink Top batches left no usable purity or quantity signal.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Cytlink rows.
Cancel anytime
| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
| 6 Nov 2026 | Fail | wfj9vsv Tested | lab name | View COA | |||
| 15 Oct 2026 | Fail | rzc47ny Tested | lab name | View COA | |||
About Cytlink test results from Finnrick
Cytlink is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 1 peptide and 2 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Cytlink peptides in this dataset are Retatrutide (2 tests), Tirzepatide (0 tests) and Ipamorelin (0 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 2 recent tests.
Ordered Retatrutide from Cytlink? Mail in a sample (US only) and let us test it.
Test my supply